查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1313411

神經血管設備市場：按病理、設備、最終用戶分類 - 全球預測 2023-2030

Neurovascular Devices Market by Disease Pathology, Devices, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球神經血管設備市場規模為32.975億美元，複合年成長率為7.03%，預計2030年將達53.1283億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球神經血管器械市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 神經血管設備的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球神經血管器械市場的阻礙因素和影響有哪些？

3.在預測期內，全球神經血管設備市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球神經血管器材市場的競爭策略是什麼？

5. 全球神經血管器械市場的技術趨勢和法律規範是什麼？

6.全球神經血管器械市場主要廠商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球神經血管器械市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 腦動脈瘤和神經病變的發生率增加
      • 微創腦部手術的需求不斷增加
      • 神經血管裝置相關技術的進步
    • 抑制因素
      • 與神經血管介入和設備相關的高成本
    • 機會
      • 神經血管治療領域的新研究活動
      • 正在進行的產品開發和神經血管設備批准
    • 任務
      • 世界上神經外科醫師的數量有限
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 依疾病病理學分類的神經血管設備市場

  • 動脈瘤
  • 動靜脈畸形和瘻管
  • 缺血性中風
  • 收縮

第7章 神經血管設備市場（按設備）

  • 腦血管成形術和支架系統
    • 栓塞圈
    • 分流器
    • 液態栓塞劑
  • 腦栓塞及動脈瘤彈簧圈栓塞裝置
    • 頸動脈支架
    • 栓塞預防系統
  • 神經血栓切除裝置
    • 血栓取出裝置
    • 吸引裝置
    • 血管圈套器
  • 支撐裝置
    • 微導管
    • 微導絲

第8章 神經血管設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第9章 美洲神經血管設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太神經血管器械市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲神經血管器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-0360AB17E212

The Global Neurovascular Devices Market is forecasted to grow significantly, with a projected USD 3,297.50 million in 2023 at a CAGR of 7.03% and expected to reach a staggering USD 5,312.83 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Neurovascular Devices Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Neurovascular Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Disease Pathology, market is studied across Aneurysm, Arteriovenous Malformation & Fistulas, Ischemic Stroke, and Stenosis. The Stenosis is projected to witness significant market share during forecast period.

Based on Devices, market is studied across Cerebral Angioplasty & Stenting Systems, Cerebral Embolization & Aneurysm Coiling Devices, Neurothrombectomy Devices, and Support Devices. The Cerebral Angioplasty & Stenting Systems is further studied across Embolic Coils, Flow Diverters, and Liquid Embolic Agents. The Cerebral Embolization & Aneurysm Coiling Devices is further studied across Carotid Artery Stents and Embolic Protection Systems. The Neurothrombectomy Devices is further studied across Clot Retrieval Devices, Suction Devices, and Vascular Snares. The Support Devices is further studied across Micro Catheters and Micro Guidewires. The Cerebral Embolization & Aneurysm Coiling Devices is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialized Clinics. The Specialized Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Neurovascular Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neurovascular Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurovascular Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurovascular Devices Market?

4. What is the competitive strategic window for opportunities in the Global Neurovascular Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Neurovascular Devices Market?

6. What is the market share of the leading vendors in the Global Neurovascular Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Neurovascular Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neurovascular Devices Market, by Disease Pathology, 2022 vs 2030
  • 4.3. Neurovascular Devices Market, by Devices, 2022 vs 2030
  • 4.4. Neurovascular Devices Market, by End-User, 2022 vs 2030
  • 4.5. Neurovascular Devices Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of a brain aneurysm and neurological disorders
      • 5.1.1.2. Rising demand for minimally invasive procedures for brain surgeries
      • 5.1.1.3. Technological advancements related to neurovascular devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the neurovascular interventions and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging research activities in the field of neurovascular therapies
      • 5.1.3.2. Ongoing product development and approvals of neurovascular devices
    • 5.1.4. Challenges
      • 5.1.4.1. Limited neurosurgeons across the globe
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Neurovascular Devices Market, by Disease Pathology

  • 6.1. Introduction
  • 6.2. Aneurysm
  • 6.3. Arteriovenous Malformation & Fistulas
  • 6.4. Ischemic Stroke
  • 6.5. Stenosis

7. Neurovascular Devices Market, by Devices

  • 7.1. Introduction
  • 7.2. Cerebral Angioplasty & Stenting Systems
    • 7.2.1. Embolic Coils
    • 7.2.2. Flow Diverters
    • 7.2.3. Liquid Embolic Agents
  • 7.3. Cerebral Embolization & Aneurysm Coiling Devices
    • 7.3.1. Carotid Artery Stents
    • 7.3.2. Embolic Protection Systems
  • 7.4. Neurothrombectomy Devices
    • 7.4.1. Clot Retrieval Devices
    • 7.4.2. Suction Devices
    • 7.4.3. Vascular Snares
  • 7.5. Support Devices
    • 7.5.1. Micro Catheters
    • 7.5.2. Micro Guidewires

8. Neurovascular Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialized Clinics

9. Americas Neurovascular Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurovascular Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurovascular Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR DEVICES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2022 VS 2030 (%)
  • FIGURE 5. NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2022 VS 2030 (%)
  • FIGURE 6. NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. NEUROVASCULAR DEVICES MARKET DYNAMICS
  • FIGURE 9. NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. NEUROVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 5. NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION & FISTULAS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 10. NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 11. NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 16. NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 20. NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 25. NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (U